Direct Flow Medical, Inc.

The global market for products treating heart valve disease is forecast to grow from $4.8bn in 2016 to $8.1bn in 2021, at a compound annual growth rate (CAGR) of 10.9%. According to Meddevicetracker

Device Transactions Financing by device companies during the third quarter of 2016 totaled $3 billion, doubling Q2's $1.5 billion. As in the past two quarters, debt offerings continue to make up the h

[ Editors' note: For more details about VC deals in 2016 and previous years, go to Medtech Insight's VC deal tracker: https://medtech.pharmamedtechbi.com/datasets/vc-funding .] At first glance,

Veteran industry executive and venture capitalist Paul LaViolette is the new board chairman of the Medical Device Manufacturers Association. MDMA announced the appointment May 11. LaViolette was elect